Report Summary
The global Rotavirus Vaccine market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Rotavirus Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Rotavirus Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rotavirus Vaccine in these regions.
This research report categorizes the global Rotavirus Vaccine market by top players/brands, region, type and end user. This report also studies the global Rotavirus Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
GSK
Sanofi
Lanzhou Institution
Market size by Product
Pentavalent Oral
Oral
Market size by End User
Government Institution
Private Sector
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Rotavirus Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Rotavirus Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Rotavirus Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Rotavirus Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Rotavirus Vaccine are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Rotavirus Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Rotavirus Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Rotavirus Vaccine Market Size Growth Rate by Product
1.4.2 Pentavalent Oral
1.4.3 Oral
1.5 Market by End User
1.5.1 Global Rotavirus Vaccine Market Size Growth Rate by End User
1.5.2 Government Institution
1.5.3 Private Sector
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rotavirus Vaccine Market Size
2.1.1 Global Rotavirus Vaccine Revenue 2017-2027
2.1.2 Global Rotavirus Vaccine Sales 2017-2027
2.2 Rotavirus Vaccine Growth Rate by Regions
2.2.1 Global Rotavirus Vaccine Sales by Regions
2.2.2 Global Rotavirus Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Rotavirus Vaccine Sales by Manufacturers
3.1.1 Rotavirus Vaccine Sales by Manufacturers
3.1.2 Rotavirus Vaccine Sales Market Share by Manufacturers
3.1.3 Global Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Rotavirus Vaccine Revenue by Manufacturers
3.2.1 Rotavirus Vaccine Revenue by Manufacturers (2017-2020)
3.2.2 Rotavirus Vaccine Revenue Share by Manufacturers (2017-2020)
3.3 Rotavirus Vaccine Price by Manufacturers
3.4 Rotavirus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rotavirus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Rotavirus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Rotavirus Vaccine Sales by Product
4.2 Global Rotavirus Vaccine Revenue by Product
4.3 Rotavirus Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Rotavirus Vaccine Breakdown Data by End User
6 North America
6.1 North America Rotavirus Vaccine by Countries
6.1.1 North America Rotavirus Vaccine Sales by Countries
6.1.2 North America Rotavirus Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Rotavirus Vaccine by Product
6.3 North America Rotavirus Vaccine by End User
7 Europe
7.1 Europe Rotavirus Vaccine by Countries
7.1.1 Europe Rotavirus Vaccine Sales by Countries
7.1.2 Europe Rotavirus Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rotavirus Vaccine by Product
7.3 Europe Rotavirus Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Rotavirus Vaccine by Countries
8.1.1 Asia Pacific Rotavirus Vaccine Sales by Countries
8.1.2 Asia Pacific Rotavirus Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Rotavirus Vaccine by Product
8.3 Asia Pacific Rotavirus Vaccine by End User
9 Central & South America
9.1 Central & South America Rotavirus Vaccine by Countries
9.1.1 Central & South America Rotavirus Vaccine Sales by Countries
9.1.2 Central & South America Rotavirus Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Rotavirus Vaccine by Product
9.3 Central & South America Rotavirus Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Rotavirus Vaccine by Countries
10.1.1 Middle East and Africa Rotavirus Vaccine Sales by Countries
10.1.2 Middle East and Africa Rotavirus Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Rotavirus Vaccine by Product
10.3 Middle East and Africa Rotavirus Vaccine by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Rotavirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Merck Rotavirus Vaccine Products Offered
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Business Overview
11.2.3 GSK Rotavirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.2.4 GSK Rotavirus Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Rotavirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Sanofi Rotavirus Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 Lanzhou Institution
11.4.1 Lanzhou Institution Company Details
11.4.2 Company Business Overview
11.4.3 Lanzhou Institution Rotavirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Lanzhou Institution Rotavirus Vaccine Products Offered
11.4.5 Lanzhou Institution Recent Development
12 Future Forecast
12.1 Rotavirus Vaccine Market Forecast by Regions
12.1.1 Global Rotavirus Vaccine Sales Forecast by Regions 2021-2027
12.1.2 Global Rotavirus Vaccine Revenue Forecast by Regions 2021-2027
12.2 Rotavirus Vaccine Market Forecast by Product
12.2.1 Global Rotavirus Vaccine Sales Forecast by Product 2021-2027
12.2.2 Global Rotavirus Vaccine Revenue Forecast by Product 2021-2027
12.3 Rotavirus Vaccine Market Forecast by End User
12.4 North America Rotavirus Vaccine Forecast
12.5 Europe Rotavirus Vaccine Forecast
12.6 Asia Pacific Rotavirus Vaccine Forecast
12.7 Central & South America Rotavirus Vaccine Forecast
12.8 Middle East and Africa Rotavirus Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rotavirus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
